Cargando…

Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment

BACKGROUND: Uterine leiomyosarcoma (ULMS) is an aggressive form of soft tissue tumors. The molecular heterogeneity and pathogenesis of ULMS are not well understood. METHODS: Expression profiling data were used to determine the possibility and optimal number of ULMS molecular subtypes. Next, clinicop...

Descripción completa

Detalles Bibliográficos
Autores principales:	An, Yang, Wang, Shuzhen, Li, Songlin, Zhang, Lulu, Wang, Dayong, Wang, Haojie, Zhu, Shibai, Zhu, Wan, Li, Yongqiang, Chen, Wenwu, Ji, Shaoping, Guo, Xiangqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594508/ https://www.ncbi.nlm.nih.gov/pubmed/28893210 http://dx.doi.org/10.1186/s12885-017-3568-y

Ejemplares similares

Identification of distinct molecular subtypes of uterine carcinosarcoma
por: An, Yang, et al.
Publicado: (2017)

Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma
por: Lamm, Wolfgang, et al.
Publicado: (2014)

The Expression of the Immunoproteasome Subunit PSMB9 Is Related to Distinct Molecular Subtypes of Uterine Leiomyosarcoma
por: Maia Falcão, Raul, et al.
Publicado: (2022)

Molecular Subtypes of Uterine Leiomyosarcoma and Correlation with Clinical Outcome()()
por: Barlin, Joyce N., et al.
Publicado: (2015)

Molecular subtyping of leiomyosarcoma with 3′ end RNA sequencing
por: Guo, Xiangqian, et al.
Publicado: (2015)

Uterine Leiomyosarcoma
por: Byar, Katherine L., et al.
Publicado: (2022)

Current Chemotherapy and Potential New Targets in Uterine Leiomyosarcoma
por: Momtahen, Shabnam, et al.
Publicado: (2016)

Prevalence and occult rates of uterine leiomyosarcoma
por: Wang, Lingxiang, et al.
Publicado: (2020)

OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine Carcinosarcoma
por: An, Yang, et al.
Publicado: (2020)

Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage
por: Patel, Dhara, et al.
Publicado: (2019)

A Case Report Of Uterine Leiomyosarcoma
por: Cao, Siyu, et al.
Publicado: (2019)

Outcomes of First-Line Chemotherapy in Patients with Advanced or Metastatic Leiomyosarcoma of Uterine and Non-Uterine Origin
por: Oosten, A. W., et al.
Publicado: (2009)

Microvessels Density in Uterine Leiomyosarcoma
por: Bobiński, Marcin, et al.
Publicado: (2015)

Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns
por: Guo, Xiangqian, et al.
Publicado: (2018)

Gene expression profile identifies distinct molecular subtypes and potential therapeutic genes in Merkel cell carcinoma
por: Saddozai, Umair Ali Khan, et al.
Publicado: (2020)

Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2011)

Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations()
por: Wang, Fengling, et al.
Publicado: (2019)

Potential Biomarker for Human Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2014)

Uterine leiomyosarcoma: A case report
por: Kaur, Khushpreet, et al.
Publicado: (2014)

The Role of Hedgehog Pathway in Uterine Leiomyosarcoma
por: Garcia, Natalia, et al.
Publicado: (2021)

Long lasting clinical response to chemotherapy for advanced uterine leiomyosarcoma: a case report
por: Ridolfi, Claudio, et al.
Publicado: (2013)

Targeting homologous recombination deficiency in uterine leiomyosarcoma
por: Dall, Genevieve, et al.
Publicado: (2023)

Perforated intestinal leiomyosarcoma as a metastasis of uterine leiomyosarcoma: a case report
por: Saylam, Barış, et al.
Publicado: (2009)

Cervical leiomyosarcoma in a teenage girl: A rare form of uterine leiomyosarcoma()
por: Adewole, Adebayo A., et al.
Publicado: (2021)

Preclinical activity of selinexor in combination with eribulin in uterine leiomyosarcoma
por: Mittal, Sonam, et al.
Publicado: (2023)

Vulvar Leiomyosarcomas: A Case Series with Clinical Comparison to Uterine Leiomyosarcomas and Review of the Literature
por: Verta, Stephanie, et al.
Publicado: (2023)

Uterine leiomyosarcoma with central nervous system metastases
por: Abrahão, Carina Meira, et al.
Publicado: (2015)

Rare Endobronchial metastasis from uterine leiomyosarcoma
por: Ghosh, Saswata, et al.
Publicado: (2015)

A Case of Renal Metastasis of Uterine Leiomyosarcoma
por: Bajic, Petar, et al.
Publicado: (2017)

Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells
por: de Almeida, Bruna Cristine, et al.
Publicado: (2017)

A Rare Case of Uterine Myxoid Leiomyosarcoma
por: Wankhade, Rashmi, et al.
Publicado: (2023)

Identification of Distinct Molecular Subtypes of Endometrioid Adenocarcinoma
por: Lei, Jia, et al.
Publicado: (2021)

Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling
por: Beck, Andrew H, et al.
Publicado: (2009)

OSlms: A Web Server to Evaluate the Prognostic Value of Genes in Leiomyosarcoma
por: Wang, Qiang, et al.
Publicado: (2019)

Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma
por: Zhou, Maggie, et al.
Publicado: (2022)

Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid
por: Zhang, Guorui, et al.
Publicado: (2020)

Uterine Leiomyosarcoma Manifesting as a Tricuspid Valve Mass
por: Marak, Creticus P., et al.
Publicado: (2013)

Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors
por: Thanopoulou, Eirini, et al.
Publicado: (2014)

Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin
por: Amant, Frédéric, et al.
Publicado: (2015)

Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8oakh06qfq4s4j0c4l563j2m40